{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T19:42:32Z","timestamp":1786304552059,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jmii.2026.07.012","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:34:40Z","timestamp":1786034080000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Doxycycline versus azithromycin as combination therapy in the empirical treatment of community-acquired pneumonia in an intensive care unit \u2013 A retrospective propensity score-matched cohort study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1766-4271","authenticated-orcid":false,"given":"Sin Man","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7002-3548","authenticated-orcid":false,"given":"Hoi Ping","family":"Shum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jmii.2026.07.012_bib1","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/cid\/cix647","article-title":"University of Louisville pneumonia study group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality","volume":"65","author":"Ramirez","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jmii.2026.07.012_bib3","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.chest.2020.03.051","article-title":"The burden of community-acquired pneumonia requiring admission to ICU in the United States","volume":"158","author":"Cavallazzi","year":"2020","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.jmii.2026.07.012_bib4","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.jmii.2026.07.012_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.18773\/austprescr.2024.024","article-title":"Controversies in the management of community-acquired pneumonia in adults","volume":"47","author":"Tucker","year":"2024","journal-title":"Aust Prescr"},{"issue":"4","key":"10.1016\/j.jmii.2026.07.012_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/23744235.2017.1399316","article-title":"Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017","volume":"50","author":"Athlin","year":"2018","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.jmii.2026.07.012_bib7","series-title":"Reducing bacterial resistance with IMPACT","year":"2025"},{"issue":"2","key":"10.1016\/j.jmii.2026.07.012_bib8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/CCM.0b013e3182a66b9b","article-title":"Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis","volume":"42","author":"Sligl","year":"2014","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jmii.2026.07.012_bib9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13054-023-04466-x","article-title":"Impact of macrolide treatment on long-term mortality in patients admitted to the ICU due to CAP: a targeted maximum likelihood estimation and survival analysis","volume":"27","author":"Reyes","year":"2023","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.jmii.2026.07.012_bib10","article-title":"Disease burden and macrolide resistance of Mycoplasma pneumoniae infection in adults in the Asia-Pacific region","volume":"64","author":"Lai","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2026.07.012_bib11","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1017\/S0950268824000323","article-title":"Macrolide resistance of Mycoplasma pneumoniae in several regions of China from 2013 to 2019","volume":"152","author":"Jiang","year":"2024","journal-title":"Epidemiol Infect"},{"issue":"5","key":"10.1016\/j.jmii.2026.07.012_bib12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/antibiotics13050406","article-title":"The interplay between antibiotics and the host immune response in sepsis: from basic mechanisms to clinical considerations: a comprehensive narrative review","volume":"13","author":"Tosi","year":"2024","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"10.1016\/j.jmii.2026.07.012_bib13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S2213-2600(23)00412-5","article-title":"Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial","volume":"12","author":"Giamarellos-Bourboulis","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.jmii.2026.07.012_bib14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/cid\/ciab863","article-title":"Effectiveness of beta-lactam plus doxycycline for patients hospitalized with community-acquired pneumonia","volume":"75","author":"Uddin","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jmii.2026.07.012_bib15","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1093\/jac\/dkad301","article-title":"\u03b2-Lactams plus doxycycline versus azithromycin for treatment of severe community-acquired pneumonia in critically ill patients","volume":"78","author":"Greco","year":"2023","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.jmii.2026.07.012_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.jmii.2026.07.012_bib17","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/aje\/kwj149","article-title":"Variable selection for propensity score models","volume":"163","author":"Brookhart","year":"2006","journal-title":"Am J Epidemiol"},{"issue":"21","key":"10.1016\/j.jmii.2026.07.012_bib18","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia","volume":"388","author":"Dequin","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jmii.2026.07.012_bib19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00134-025-07861-w","article-title":"Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia : the REMAP-CAP corticosteroid domain randomized clinical trial","volume":"51","author":"Angus","year":"2025","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jmii.2026.07.012_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106307","article-title":"Pneumococal community-acquired pneumonia in the intensive care unit: Azithromycin remains protective despite macrolide resistance","volume":"177","author":"Shorr","year":"2021","journal-title":"Respir Med"},{"issue":"11","key":"10.1016\/j.jmii.2026.07.012_bib21","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1164\/rccm.200712-1777OC","article-title":"Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis","volume":"177","author":"Yende","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.jmii.2026.07.012_bib22","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.clinthera.2019.10.005","article-title":"Outcomes of macrolide deescalation in severe community-acquired pneumonia","volume":"41","author":"Hopkins","year":"2019","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.jmii.2026.07.012_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1164\/rccm.202005-1916OC","article-title":"Inhibition of Caspase-1 with tetracycline ameliorates acute lung injury","volume":"204","author":"Peukert","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.jmii.2026.07.012_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae470","article-title":"High rates of nonsusceptibility to common oral antibiotics in Streptococcus pneumoniae clinical isolates from the United States (2019-2021)","volume":"11","author":"Deshpande","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"Suppl-1","key":"10.1016\/j.jmii.2026.07.012_bib25","first-page":"S188","article-title":"Resistance emergence of doxycycline against Staphylococcus aures and Streptococcus pneumoniae","volume":"70","author":"Bushra","year":"2020","journal-title":"Pak Armed Forces Med J"},{"issue":"1","key":"10.1016\/j.jmii.2026.07.012_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2482703","article-title":"Characterizing the epidemiology of Mycoplasma pneumoniae infections in China in 2022-2024: a nationwide cross-sectional study of over 1.6 million cases","volume":"14","author":"Sun","year":"2025","journal-title":"Emerg Microb Infect"},{"issue":"12","key":"10.1016\/j.jmii.2026.07.012_bib28","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/INF.0b013e3182a25c71","article-title":"Rapid defervescence after doxycycline treatment of macrolide-resistant mycoplasma pneumoniae-associated community-acquired pneumonia in children","volume":"32","author":"Lung","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"15","key":"10.1016\/j.jmii.2026.07.012_bib29","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.7150\/ijms.99233","article-title":"Clinical and epidemiologic features of Mycoplasma pneumoniae infection among adults hospitalized with community-acquired pneumonia","volume":"21","author":"Kutty","year":"2024","journal-title":"Int J Med Sci"},{"issue":"7","key":"10.1016\/j.jmii.2026.07.012_bib30","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1473-3099(24)00805-3","article-title":"Mycoplasma pneumoniae infection in adult inpatients during the 2023-24 outbreak in France (MYCADO): a national, retrospective, observational study","volume":"25","author":"Gavaud","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2026.07.012_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2019.e00540","article-title":"Legionnaire's disease presenting with encephalitis, myoclonus, and seizures: successful treatment with doxycycline","volume":"17","author":"Cunha","year":"2019","journal-title":"IDCases"},{"issue":"1","key":"10.1016\/j.jmii.2026.07.012_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13613-024-01252-y","article-title":"Severe legionnaires' disease","volume":"14","author":"Rello","year":"2024","journal-title":"Ann Intensive Care"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118226000988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118226000988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T19:23:32Z","timestamp":1786303412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118226000988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"alternative-id":["S1684118226000988"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2026.07.012","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Doxycycline versus azithromycin as combination therapy in the empirical treatment of community-acquired pneumonia in an intensive care unit \u2013 A retrospective propensity score-matched cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2026.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}